Human amniotic membrane-derived stromal cells (hAMSC) interact depending on breast cancer cell type through secreted molecules.

[1]  M. Matúšková,et al.  Altered features and increased chemosensitivity of human breast cancer cells mediated by adipose tissue-derived mesenchymal stromal cells , 2013, BMC Cancer.

[2]  S. Yoo,et al.  Character comparison of abdomen‐derived and eyelid‐derived mesenchymal stem cells , 2013, Cell proliferation.

[3]  N. Ferrari,et al.  Impact of CXCL1 overexpression on growth and invasion of prostate cancer cell , 2013, The Prostate.

[4]  Weian Zhao,et al.  To grab the stroma by the horns: From biology to cancer therapy with mesenchymal stem cells , 2013, Oncotarget.

[5]  G. Landberg,et al.  Targeting CXCR1/2 Significantly Reduces Breast Cancer Stem Cell Activity and Increases the Efficacy of Inhibiting HER2 via HER2-Dependent and -Independent Mechanisms , 2012, Clinical Cancer Research.

[6]  S. Kang,et al.  Journey of Mesenchymal Stem Cells for Homing: Strategies to Enhance Efficacy and Safety of Stem Cell Therapy , 2012, Stem cells international.

[7]  Kwang-Huei Lin,et al.  Overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[9]  F. Jenhani,et al.  Human cytokine expression profile in various conditioned media for in vitro expansion bone marrow and umbilical cord blood immunophenotyped mesenchymal stem cells. , 2011, Transplantation proceedings.

[10]  C. Cicione,et al.  Human amniotic membrane as an alternative source of stem cells for regenerative medicine. , 2011, Differentiation; research in biological diversity.

[11]  M. Andreeff,et al.  Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth? , 2010, Stem cells.

[12]  J. Vykoukal,et al.  Adipose tissue‐derived stem cells promote prostate tumor growth , 2010, The Prostate.

[13]  S. Díaz-Prado,et al.  Multilineage differentiation potential of cells isolated from the human amniotic membrane , 2010, Journal of cellular biochemistry.

[14]  N. Miller,et al.  Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT) , 2010, Breast Cancer Research and Treatment.

[15]  D. Covas,et al.  Mechanisms involved in the therapeutic properties of mesenchymal stem cells. , 2009, Cytokine & growth factor reviews.

[16]  J. Kim,et al.  Overexpression of CXC chemokine receptors is required for the superior glioma-tracking property of umbilical cord blood-derived mesenchymal stem cells. , 2009, Stem cells and development.

[17]  I. Manabe,et al.  IFATS Collection: Fibroblast Growth Factor‐2‐Induced Hepatocyte Growth Factor Secretion by Adipose‐Derived Stromal Cells Inhibits Postinjury Fibrogenesis Through a c‐Jun N‐Terminal Kinase‐Dependent Mechanism , 2009, Stem cells.

[18]  Ross Tubo,et al.  Mesenchymal stem cells within tumour stroma promote breast cancer metastasis , 2007, Nature.

[19]  M. Kerin,et al.  Monocyte Chemotactic Protein-1 Secreted by Primary Breast Tumors Stimulates Migration of Mesenchymal Stem Cells , 2007, Clinical Cancer Research.

[20]  Yukio Nakamura,et al.  Differentiation of mesenchymal cells derived from human amniotic membranes into hepatocyte-like cells in vitro , 2007, Human Cell.

[21]  O. Parolini,et al.  Isolation and characterization of mesenchymal cells from human fetal membranes , 2007, Journal of tissue engineering and regenerative medicine.

[22]  V. Lionetti,et al.  Hyaluronan Mixed Esters of Butyric and Retinoic Acid Drive Cardiac and Endothelial Fate in Term Placenta Human Mesenchymal Stem Cells and Enhance Cardiac Repair in Infarcted Rat Hearts* , 2007, Journal of Biological Chemistry.

[23]  V. Fossati,et al.  Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro , 2007, BMC Developmental Biology.

[24]  H. Kim,et al.  Human amniotic fluid‐derived stem cells have characteristics of multipotent stem cells , 2007, Cell proliferation.

[25]  Wei Huang,et al.  Isolation of mesenchymal stem cells from human placenta: Comparison with human bone marrow mesenchymal stem cells , 2006, Cell biology international.

[26]  M. Raffeld,et al.  Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma , 2006, The Journal of experimental medicine.

[27]  Shiaw-Min Hwang,et al.  Cytokine interactions in mesenchymal stem cells from cord blood. , 2005, Cytokine.

[28]  W. Holzgreve,et al.  Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. , 2005, American journal of obstetrics and gynecology.

[29]  T. Nikaido,et al.  Human Amniotic Mesenchymal Cells Have Some Characteristics of Cardiomyocytes , 2005, Transplantation.

[30]  F. Claas,et al.  Isolation of Mesenchymal Stem Cells of Fetal or Maternal Origin from Human Placenta , 2004, Stem cells.

[31]  H. Okano,et al.  Human amnion mesenchyme cells express phenotypes of neuroglial progenitor cells , 2004, Journal of neuroscience research.

[32]  M. Burnett,et al.  Local Delivery of Marrow-Derived Stromal Cells Augments Collateral Perfusion Through Paracrine Mechanisms , 2004, Circulation.

[33]  Keith L. March,et al.  Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal Cells , 2004, Circulation.

[34]  T. Nikaido,et al.  Human Amnion-Isolated Cells Normalize Blood Glucose in Streptozotocin-Induced Diabetic Mice , 2003, Cell transplantation.

[35]  C. Fuhrer,et al.  Laminin-1 redistributes postsynaptic proteins and requires rapsyn, tyrosine phosphorylation, and Src and Fyn to stably cluster acetylcholine receptors , 2002, The Journal of cell biology.

[36]  Albert D Donnenberg,et al.  Regenerative therapy and cancer: in vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates. , 2011, Tissue engineering. Part A.